Published in Medical Imaging Business Week, December 31st, 2009
AIM, a leading diagnostic imaging benefit management and technology company with health plan clients representing over 35 million consumers and an operating subsidiary of WellPoint, Inc. (NYSE:WLP), adapted the successful clinical and technology platform used by the company to manage diagnostic imaging to meet the growing challenge of specialty pharmaceuticals, which include drugs that are typically high-cost oral and injectable medications...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.